BackgroundCheck.run
Search For

Xin G Gu, 41Boston, MA

Known as:
Xin S Gu
Related to:
Brian D Lemberg 38 Adriana Dantas Lemberg Victor Gu 46 Songhua Gu 68

Xin Gu Phones & Addresses

Allston, MA   

6411 99Th St APT 602, Rego Park, NY 11374   

Flushing, NY   

Cambridge, MA   

Somerville, MA   

Newton, MA   

180 Brookline Ave UNIT 739, Boston, MA 02215   

Get Report
Control this profile

Mentions for Xin G Gu

Career records & work history

Medicine Doctors

Xin Gu

Specialties:
Immunology, Clinical Pathology
Work:
Louisiana State University Health Center Pathology
1501 Kings Hwy FL 2, Shreveport, LA 71103
318-6758848 (phone) 318-6758589 (fax)
Education:
Medical School
Capital Univ of Med Scis, Training Ctr of Gen Prac, Beijing City, China
Graduated: 1983
Languages:
English
Description:
Dr. Gu graduated from the Capital Univ of Med Scis, Training Ctr of Gen Prac, Beijing City, China in 1983. He works in Shreveport, LA and specializes in Immunology and Clinical Pathology. Dr. Gu is affiliated with University Health Center.

License Records

Xin Gu

Address:
Rego Park, NY 11374
Licenses:
License #: 31961 - Active
Issued Date: Feb 25, 2015
Expiration Date: Jun 30, 2018
Type: Certified Public Accountant

Xin Gu resumes & CV records

Resumes

Xin Gu Photo 38

Cloud Application Architect

Location:
Boston, MA
Industry:
Computer Software
Work:
Amazon Web Services
Cloud Application Architect Exa Corporation Jul 2015 - Aug 2017
Manager, Thermal Physics Exa Corporation Apr 1, 2013 - Jul 2015
Senior Physics Validation Engineer Exa Corporation Feb 2011 - Apr 2013
Software Validation Engineer University of Central Florida Aug 2006 - May 2012
Phd In Mechanical Engineering University of Central Florida Aug 2006 - Jan 2011
Graduate Research Assistant
Education:
University of Central Florida 2007 - 2012
Doctorates, Doctor of Philosophy, Philosophy, Mechanical Engineering University of Central Florida 2006 - 2009
Master of Science, Masters, Mechanical Engineering Cfa Institute
Skills:
Git, Javascript, Angularjs, Gulp.js, Node.js, Heat Transfer, Thermodynamics, Thermal, Solidworks, Python, Karma/Jasmine, Cfd, Financial Accounting, Financial Modeling, Investments, Dcf Valuation, Express.js, Php, Tecplot, Fortran, C++, Computational Fluid Dynamics, Physics, Shell Scripting, Numerical Simulation, Mechanical Engineering, Mysql, Unix/Linux, Ptc Pro/Engineer, Matlab, Numerical Analysis, Turbulence Modeling, Powerflow, Nosql/Mongodb, Java, Spring Security, Grails, Simulations
Languages:
Mandarin
English
Certifications:
Startup Engineering
Xin Gu Photo 39

Yoga Teacher

Location:
Boston, MA
Industry:
Health, Wellness And Fitness
Work:
Kamal Yoga Beijing Studio Jan 2014 - Aug 2014
Yoga Instructor Jan 2014 - Aug 2014
Yoga Teacher
Education:
China University of Political Science and Law 2006 - 2009
Masters, Law Beijing University of Posts and Telecommunications 2002 - 2006
Bachelors, Law
Skills:
Yoga, Personal Training, Has Errors, Yoga Therapy, Great, Hatha Yoga, Pranayama, Mindfulness Meditation
Interests:
Social Services
Children
Economic Empowerment
Civil Rights and Social Action
Traveling
Education
Poverty Alleviation
Science and Technology
Hiking
Human Rights
Digital Photography
Animal Welfare
Health
Languages:
Chinese
English
Certifications:
License Registry Id: 151144
Yoga Alliance, License Registry Id: 151144
Xin Gu Photo 40

Xin Gu

Xin Gu Photo 41

Xin Gu

Xin Gu Photo 42

Xin Gu

Xin Gu Photo 43

Xin Gu - New York, NY

Work:
Lord, Abbett & Co Oct 2011 to 2000
Fixed Income Trade Support, Senior Associate Goldman, Sachs & Co - New York, NY Jul 2010 to Aug 2011
Structured Products Middle Office, Analyst Credit Derivatives Settlements Jul 2008 to Jul 2010
Analyst
Education:
Stevens Institute of Technology - Hoboken, NJ May 2008
Bachelor of Engineering in Electrical Engineering New York University, Leonard N. Stern School of Business - New York, NY
Master of Business Administration
Xin Gu Photo 44

Xin Gu - New York, NY

Work:
JK Studio Feb 2012 to 2000
Business Strategy Manager Chiman Capital - New York, NY Jun 2010 to Oct 2011
Business Strategy Consultant MTR Securities LLC - New York, NY Sep 2009 to Feb 2010
Assistant Vice President UBS Securities LLC - New York, NY Mar 2002 to Nov 2007
Associate
Education:
Northeastern University - Boston, MA 2001
Bachelor of Science in Business Administration
Skills:
Fluent in written and spoken English and Chinese (Mandarin & Shanghaiese) Attuned to Chinese culture and its impact on business Proficient in MS-Office Suite, Bloomberg, Financial Modeling Software

Publications & IP owners

Us Patents

Diaryltriazoles As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase-1

US Patent:
8178546, May 15, 2012
Filed:
Apr 14, 2010
Appl. No.:
12/759737
Inventors:
Susan D. Aster - Teaneck NJ, US
James M. Balkovec - Martinsville NJ, US
Donald W. Graham - Mountainside NJ, US
Xin Gu - Scotch Plains NJ, US
Nancy J. Kevin - East Brunswick NJ, US
Gool F. Patel - Califon NJ, US
Mitree Ponpipom - Branchburg NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 249/08
US Classification:
5142664
Abstract:
2,5-Diaryl-1,2,4-triazole derivatives of structural formula I are selective inhibitors of the 11β-hydroxysteroid dehydrogenase Type 1 enzyme (11β-HSD-1). The compounds are useful for the treatment of diabetes, hyperglycemia, obesity, insulin resistance, atherosclerosis, dyslipidemia, hyperlipidemia, hypertension, and Metabolic Syndrome. Also disclosed are novel compounds of structural formula II which are inhibitors of 11β-HSD-1.

Diaryltriazoles As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase-1

US Patent:
2008025, Oct 16, 2008
Filed:
Mar 25, 2005
Appl. No.:
10/593010
Inventors:
Susan D. Aster - Teaneck NJ, US
James M. Balkovec - Martinsville NJ, US
Donald W. Graham - Mountainside NJ, US
Xin Gu - Scotch Plains NJ, US
Nancy J. Kevin - East Brunswick NJ, US
Gool F. Patel - Califon NJ, US
Mitree Ponpipom - Branchburg NJ, US
International Classification:
A61K 31/4196
C07D 249/08
A61P 3/04
A61P 9/12
A61P 9/10
A61P 3/10
C07D 403/02
US Classification:
514383, 5482622, 5482664
Abstract:
2,5-Diaryl-1,2,4-triazole derivatives of structural formula I are selective inhibitors of the 11&bgr;-hydroxysteroid dehydrogenase Type 1 enzyme (11&bgr;-HSD-1). The compounds are useful for the treatment of diabetes, hyperglycemia, obesity, insulin resistance, atherosclerosis, dyslipidemia, hyperlipidemia, hypertension, and Metabolic Syndrome. Also disclosed are novel compounds of structural formula II which are inhibitors of 11&bgr;-HSD-1.

Metallo-Beta-Lactamase Inhibitors And Methods Of Use Thereof

US Patent:
2020037, Dec 3, 2020
Filed:
Dec 20, 2018
Appl. No.:
16/769670
Inventors:
Alexander PASTERNAK - Kenilworth NJ, US
Shuzhi DONG - Kenilworth NJ, US
Jack D. SCOTT - Kenilworth NJ, US
Haiqun TANG - Kenilworth NJ, US
Zhiqiang ZHAO - Kenilworth NJ, US
Dexi YANG - Kenilworth NJ, US
Li XIAO - Kenilworth NJ, US
Xin GU - Scotch Plains NJ, US
- Rahway NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/4985
C07D 487/04
C07D 471/04
A61K 31/4439
A61K 31/519
A61K 31/4188
C07D 513/04
C07D 403/10
A61K 31/4178
A61K 31/407
A61K 31/496
A61K 31/165
A61K 31/7048
A61K 31/546
A61P 31/04
Abstract:
The present invention relates to metallo-β-lactamase inhibitor compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein R, R, and Z are as defined herein. The present invention also relates to compositions which comprise a metallo-β-lactamase inhibitor compound of the invention or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, optionally in combination with a beta lactam antibiotic and/or a beta-lactamase inhibitor. The invention further relates to methods for treating a bacterial infection comprising administering to a patient a therapeutically effective amount of a compound of the invention, in combination with a therapeutically effective amount of one or more β-lactam antibiotics and optionally in combination with one or more beta-lactamase inhibitor compounds. The compounds of the invention are useful in the methods described herein for overcoming antibiotic resistance.

Methods Of Identifying Modulators Of Samtor-Gator1 Interaction And Use Of Same To Modulate Mtorc1

US Patent:
2019023, Aug 1, 2019
Filed:
Oct 18, 2018
Appl. No.:
16/164644
Inventors:
- Cambridge MA, US
Xin Gu - Cambridge MA, US
Jose M. Orozco - Boston MA, US
International Classification:
G01N 33/534
G01N 33/50
Abstract:
The invention relates to methods of identifying compounds that modulate mTORC1 activity in a cell by modulating the activity of SAMTOR, as well as to the use of such identified compounds in the modulation of mTORC1 and the treatment of diseases and conditions characterized by aberrant mTORC1 activity.

Inhibitors Of The Renal Outer Medullary Potassium Channel

US Patent:
2017027, Sep 28, 2017
Filed:
Oct 26, 2015
Appl. No.:
15/505277
Inventors:
Alexander PASTERNAK - Kenilworth NJ, US
Shuzhi DONG - Kenilworth NJ, US
Jinlong JIANG - Kenilworth NJ, US
Haifeng TANG - Kenilworth NJ, US
Xin GU - Kenilworth NJ, US
Reynalda K. DEJESUS - Kenilworth NJ, US
Jessica FRIE - West Point PA, US
Qinghong FU - Plainsboro NJ, US
Takao SUZUKI - Shanghai, CN
Zhifa PU - Shanghai, CN
- Rahway NJ, US
International Classification:
C07D 471/10
C07D 498/10
A61K 31/5386
A61K 45/06
A61K 31/435
A61K 31/537
C07D 498/20
A61K 31/553
A61K 31/499
A61K 31/55
Abstract:
The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

Inhibitors Of The Renal Outer Medullary Potassium Channel

US Patent:
2016032, Nov 10, 2016
Filed:
Dec 19, 2014
Appl. No.:
15/101481
Inventors:
Shuzhi DONG - Kenilworth NJ, US
Alexander PASTERNAK - Kenilworth NJ, US
Xin GU - Kenilworth NJ, US
Qinghong FU - Plainsboro NJ, US
Jinlong JIANG - Kenilworth NJ, US
Haifeng TANG - Kenilworth NJ, US
Reynalda K. DEJESUS - Kenilworth NJ, US
Takao SUZUKI - Shanghai, CN
- Rahway NJ, US
International Classification:
A61K 31/435
C07D 471/10
A61K 31/444
A61K 31/506
A61K 31/438
C07D 498/10
A61K 31/537
A61K 31/497
C07D 519/00
A61K 31/437
A61K 45/06
A61K 31/501
Abstract:
Novel spirocyclic compounds of formula I: and pharmaceutically acceptable salts thereof are disclosed as inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention. Pharmaceutical compositions and methods of treatment are also included.

Inhibitors Of The Renal Outer Medullary Potassium Channel

US Patent:
2016000, Jan 7, 2016
Filed:
Feb 12, 2014
Appl. No.:
14/768245
Inventors:
Alexander PASTERNAK - Kenilworth NJ, US
Reynalda Keh DE JESUS - Kenilworth NJ, US
Shuzhi DONG - Kenilworth NJ, US
Jessica FRIE - West Point PA, US
Xin GU - Kenilworth NJ, US
Jinlong JIANG - Kenilworth NJ, US
Aurash SHAHRIPOUR - Kenilworth NJ, US
Barbara PIO - Kenilworth NJ, US
Haifeng TANG - Kenilworth NJ, US
Shawn WALSH - Kenilworth NJ, US
- Rahway NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 498/04
A61K 45/06
A61K 31/4985
A61K 31/5383
C07D 487/04
Abstract:
The present invention provides compounds of Formula Iand the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure, kidney disease, edema, and conditions associated with excessive salt and water retention.

Possible Relatives

Dan Gu  Emily G Gu  Eric Gu  Fei F Gu  Feng Gu  Gary C Gu  George Gu  Xin Li  Xin Lin  Xin Liu 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.